Brentwood, Tenn, Feb. 19, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announces that it has been invited to ring the opening bell at the Nasdaq MarketSite at New York City’s Times Square tomorrow morning, February 20, 2019. Jeff Ervin, chief executive officer, will ring the bell in celebration of the Company’s initial public offering which was completed last week.
Mr. Ervin will be joined by members of the IMAC management team and brand ambassador partners, Tony Delk, former professional basketball player and Ozzie Smith, former professional baseball player and hall-of-famer.
“The ringing of the opening bell is an exciting way to begin our journey as a publicly traded company and we are honored to have this opportunity,” said Jeff Ervin. “We hope that our presence at the Nasdaq MarketSite will draw attention to IMAC as we work to transform the company into a significant player in the regenerative rehabilitation space as we grow patient visits through our unique and patient-focused therapies, add additional centers, and highlight in particular our approach to treating musculoskeletal disorders without the use of surgery or opioids.”
A live stream of the Nasdaq Opening Bell will be available at https://new.livestream.com/nasdaq/live
About IMAC Holdings, Inc.
IMAC Holdings was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life science advancements with traditional medical care for movement restricting diseases and conditions. It owns or manages outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes, opening two Ozzie Smith IMAC Regeneration Centers, two David Price IMAC Regeneration Centers, and a Tony Delk IMAC Regeneration Center. IMAC’s outpatient medical clinics emphasize its focus around treating sports and orthopedic injuries without surgery or opioids.
Safe Harbor Statement
This press release contains forward-looking statements. These forward-looking statements, and terms such as “anticipate,” “expect,” “believe,” “may,” “will,” “should” or other comparable terms, are based largely on IMAC's expectations and are subject to a number of risks and uncertainties, certain of which are beyond IMAC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the skills and experience necessary to meet customers’ requirements, and its ability to protect its intellectual property. IMAC encourages you to review other factors that may affect its future results in its registration statement and in its other filings with the Securities and Exchange Commission. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will in fact occur.
More information about IMAC Holdings, Inc. is available at www.imacregeneration.com
IMAC Press Contact:
Laura Fristoe, lfristoe@imacrc.com
615-237-1230
Investors
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com